The cardiovascular needle market is vital to the medical goods industry. This is mainly because cardiovascular problems are spreading worldwide. Cardiovascular needles are needed for open-heart operations, circulatory therapies, and heart repairs.
Market growth is driven by increased cardiovascular disease rates. Poor diet, inactivity, and aging increase heart disease rates. This makes cardiovascular needles more common in medical treatments.
Technology has changed the circulatory needle industry. Modern materials and procedures make cardiovascular needles more precise and effective. Safe materials, high-tech coatings, and improved needle designs improve patient outcomes.
Patients seek speedier healing and fewer side effects following surgery, therefore doctors are using somewhat invasive therapies. Circulatory gadgets for minimally invasive therapies are in high demand. This demand increase matches what the medical industry is observing.
The rise of healthcare facilities worldwide has made modern medicine more accessible. This increased circulatory needle usage. The company is growing because emerging nations are doing more cardiac surgery and treatments.
Health authorities worldwide regulate the circulation needle industry by tight criteria. Market participants must follow these requirements for safe and effective products. This demands rigorous testing and quality control.
Multiple large firms compete for market domination, making it tricky. Mergers and acquisitions are a major trend that helps firms improve their products and expand globally.
Business expansion is hindered by healthcare payment issues and expense caps. Heart medications are pricey and need particular gear. This might restrict market expansion, particularly in poor healthcare areas.
Research and development are affecting arterial needles. Manufacturers are investing in more specialized and efficient suturing instruments to reduce discomfort, speed up the process, and improve outcomes.
In arterial needle sales, patient safety is paramount. Needle-related tissue damage and infections demonstrate the need to constantly improve needle design and manufacture.
Due to the growing importance of sustainability, the cardiovascular needle market is adopting greener goods and manufacturing processes. This shows how the healthcare industry is working to reduce its environmental impact.
The cardiovascular needle market size is expected to reach USD 146.9 million by 2030 at 6.2% CAGR during the forecast period 2022-2030. Cardiovascular needles are used as a part of various heart and vascular mediations to close the surgical wound. Various surgeries such as cardiovascular surgeries, open heart surgery, cardiac valve procedures, heart transplant, coronary artery bypass graft surgery, and many more surgeries need surgical needles. Rising number of a patient having cardiovascular disease, diabetes, obesity and increasing aging population is driving the market.
However, increasing use of surgical staples instead of needles and suture can deter the demand for cardiovascular needles.
Cardiovascular Needle Market Segmentations
The global cardiovascular needle market is segmented on the basis of types, by application, by usage, and by the end user.
On the basis of the type, it is segmented into round bodied needles and cutting needles. Furthermore, round-bodied needles segmented into taper point needles and blunt point needles. Also, cutting needles segmented into conventional cutting needles and reverse cutting needles. Â
On the basis of the application, it is segmented into open heart surgery, cardiac valve procedures, coronary artery bypass graft surgery, heart transplant, and others. Â
On the basis of the usage, it is segmented into single use and multiple uses.
On the basis of the end user, it is segmented into hospitals, clinics, ambulatory surgical centers, and others.
Cardiovascular Needle Market Regional Analysis
The Americas dominate the global cardiovascular needle market owing to the rising prevalence of diabetes, obesity, and cardiovascular diseases. Furthermore increasing government support for research & development have fuelled the growth of the market in this region. According to the American Heart Association, in 2017, cardiovascular disease listed as the underlying cause of death which is likely to account for nearly 801,000 deaths in the US by the end of this year. It further estimated that about 2,200 Americans die of cardiovascular disease each day.
Europe holds the second position in the global market owing to the presence of major players. Although companies within this region are also involved in export to the developing countries which leads the market of Europe.
The Asia Pacific is the fastest growing market owing to the high presence of a patient with cardiovascular disease. Furthermore, the government of this region is looking forward to better the quality of needles, which increases the demand for cardiovascular needle market in this region.
On the other hand, in the Middle East and Africa hold the least market due to low research and development activities and poor healthcare infrastructure.
Cardiovascular Needle Market Key Players
Some of the key the players in the cardiovascular needles market are Becton, Dickinson, and Company (US), B. Braun Melsungen AG (Germany), Sheffield Ltd. (UK), CP Medical, Inc. (the US), Ethicon Inc. (US), KLS Martin Group (US), Sklar Surgical Instruments (US), Rumex International Corporation Ltd. (US), Scanlan International Inc. (US), Teleflex Incorporated (US), Medline Industries, Inc. (US), Surgins surgical Ltd. (UK), Surtex Instruments Ltd. (UK), Cardivon Surgical Inc. (China), Symmetry Surgical Inc. (US), Delacroix-Chevalier (France), Wexler Surgical (US), Quality Needles Pvt. Ltd. (India), FSSB surgical needles GmbH (Germany)
Intended Audience
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)